Molecular Docking Study, and In Vitro Evaluation of Antitumor Activity of Some New Isoxazoline and Pyrazoline Derivatives of Nabumetone Against Breast Cancer Cell Line (MCF-7). AJPS 2022, 22 (3), 24-34. https://doi.org/10.32947/ajps.v22i3.886.